A biotech developing a synthetic biology Covid-19 vaccine comes up short in first data readout — and investors are fleeing
One of the biotechs betting on its vaccine platform proving useful in the long-term fight against Covid-19 reported a new batch of data Friday morning …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
